跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞易宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Glipizide Extended Release Tablets
Approved
化学药品
Glipizide Extended Release Tablets
PFIZER INC.
🇨🇳 National Medical Products Administration
Approval Date
Apr 23, 2020
Approval ID
7MazXbN9XAJ
Company
PFIZER INC.
Type
化学药品
Approval Details
Approval Id
7MazXbN9XAJ
Approval Number
H20150361
Generic Name
格列吡嗪控释片
Generic Name En
Glipizide Extended Release Tablets
Trade Name
瑞易宁
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2020-04-23
Expired Date
2025-04-22
Company Name
PFIZER INC.
Company Address
66 Hudson Boulevard East, New York, NY 10001 United States of America
Production Company Name
Viatris Pharmaceuticals LLC
Production Company Address
Road # 2 KM 58.2, Barceloneta, Puerto Rico (PR) 00617, USA
Company Detail Path
/organization/pfizer-inc
Production Company Detail Path
/organization/viatris-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 23, 2020
Approval ID
7MazXbN9XAJ
Type
化学药品
Back to NMPA Approvals